Table 2 The association between the distant metastases with baseline NLR
From: Hematologic markers of distant metastases and poor prognosis in gynecological cancers
Distant metastases | |||||
|---|---|---|---|---|---|
Present | Absent | p-value | OR | CI | |
NLR ≥ 4.1 | 51 (58.6%) | 36 (41.4%) | 0.045 | 1.7 | (1.01–2.8) |
NLR < 4.1 | 80 (46.0%) | 94 (54.0%) | |||
PLR ≥ 0.3 | 35 (53.8%) | 30 (46.2%) | 0.025 | 1.21 | (0.7–2.1) |
PLR < 0.3 | 96 (49.0%) | 100 (51.0%) | |||
AMC ≥ 560 | 84 (54.2%) | 71 (45.8%) | 0.04 | 1.5 | (0.9–2.4) |
AMC < 560 | 47 (44.3%) | 59 (55.7%) | |||